A Review of Stereotactic Radiosurgery in the Management of Brain Metastases
|
|
- Elisabeth Stewart
- 5 years ago
- Views:
Transcription
1 Technology in Cancer Research & Treatment /SSN / \kllume 2. Number 2. April (2003) Adenine Press (2003) A Review of Stereotactic Radiosurgery in the Management of Brain Metastases Paul W. Sperduto, M.D. Methodist Hospital Minneapolis. Minnesota This review addresses the epidemiology, historical reports, current issues, data and controversies involved in the management of brain metastases. The literature regarding surgery, whole brain radiation therapy, stereotactic radiosurgery or some combination of those treatments is discussed as well as issues of cost-effectiveness. Ongoing prospective randomized trials will further elucidate the optimal management for patients with brain metastases. Until those data are available, clinicians are encouraged to apply the existing data reviewed here in conjunction with best clinical judgment. A brief clinical guide is as follows. Patients with a solitary metastasis in an operable location and symptomatic mass effect should undergo surgery. Patients with poor performance status (KPS < 70) or more than three brain metastases should receive WBRT alone. Patients with 1-3 brain metastases and KPS ~ 70, should receive WBRT + SRS. If the patient refuses WBRT or needs salvage after WBRT, then SRS alone is appropriate. Clinicians should not be too dogmatic and should always apply the best clinical judgment. Key words: stereotactic radiosurgery, radiation therapy, brain metastases Introduction Metastases to the brain are the most common malignancy affecting the brain (1-3). Autopsy series have shown that as many as 25% of patients who die of cancer will have intracranial metastases. involving brain parenchyma in about 15% (3. 4). The majority of patients with intraparenchymal metastases have only one or two or three metastases. 49%. 21%. and 10%. respectively. and the remaining 20% have more than three. Approximately 80% of brain metastases are located supratentorially (5). Historically. the standard treatment for patients with brain metastases has been glucocorticoids and whole brain irradiation (WBRT) which effectively relieve symptoms and restore neurological function in most patients (3). Untreated patients have a median survival time (MST) of less than 7 weeks (6). Three prospective randomized trials involving more than 1800 patients conducted by the Radiation Therapy Oncology Group (RTOG) evaluated 9 different radiation doses and schedules (7). All doses up to 50 Gray (Gy) were equivalent with respect to toxicity. neurological improvement. and survival. Higher doses resulted in greater neurologic toxicity. Median survival time (MST) of all patient subgroups were three to six months. Little difference was found between patients who received 20 Gy administered over one week and 40 Gy administered over four weeks. Furthermore. radiation boost treatment to the metastatic site did not improve these parameters when compared to WBRT (8). Detailed quality of life measurement tools were not part of these studies. * Corresponding Author: Paul W. Sperduto, M.D. psperduto@mropa.com 105
2 106 Sperduto The most common cancers to metastasize to brain are lung and breast, 34 and 30%, respectively. Of the approximately 200,000 patients with these malignancies who will die each year, 124,000 will have brain metastases (9). The cause of death in almost 30-50% is persistence oflesions or recurrence following WBRT; however, 10 to 15% of patients will survive at least one year (9, 10). These data, along with the fact that brain metastases are so frequently three or fewer, provide the rationale for the development of treatment modalities that exceed current palliative measures to actually improve patient survival, neurocognitive function and/or quality-of-life. Review ofthe Surgery Literature There is extensive literature on the surgical management of brain metastases. The salient literature can be briefly summarized as follows. Surgical resection of solitary brain metastases is increasingly performed on patients with favorable prognostic factors, accessible lesion(s), and/or metastatic lesions from relatively radio-insensitive tumors such as renal cell carcinoma and melanoma (8, 11-16). Since metastases are usually well demarcated from surrounding brain, complete removal with a minimum of morbidity and mortality is often possible. Relief of symptoms of intracranial hypertension and focal brain dysfunction has been demonstrated. Patient survival is also dependent on the extent of extracranial disease. Resection preceding WBRT appears to improve survival compared to WBRT alone. Two prospective randomized trials in which surgical excision followed by radiation therapy compared to radiation therapy alone in patients with single metastases have been done (17, 18). Patchell and colleagues randomized patients with single metastases to either surgical excision followed by WBRT (25 pts) or biopsy followed by WBRT (23 pts). In this study, the MST (40 vs. 21 weeks), the duration of functional independence (38 vs. 8 weeks), and the rate of intracranial recurrence (20% vs. 52%) were improved with surgery and WBRT compared to WBRT alone. These results confirmed those ofearlier uncontrolled studies showing the benefits ofsurgical resection (13, 19). Vecht et a/. randomized 63 patients to the same regimens with similar results (18). Bindal et a/., in a retrospective analysis of 56 patients with multiple resected metastases, 50% of whom received WBRT, reported a MST equivalent to that of patients with a single resected metastasis but longer than that of patients who had one or more lesions remaining after surgery (9). Based on these reports, surgical removal in patients with a solitary accessible lesion followed by WBRT appears superior to WBRT alone for selected patients. The post-operative delivery of WBRT for such patients has been considered beneficial to sterilize residual disease in the tumor bed or other sites of occult disease in the brain. For patients who have undergone removal of solitary brain metastases, the addition of WBRT appears to result in a lower inci- denee of brain recurrence. The University of Kentucky randomized patients with single brain metastases to surgery alone (46 patients), or surgery followed by WBRT (49 patients) (20). Although MST and functional independence survival times of the two groups were similar, local recurrence occurred in 46 and 10%, respectively with distant recurrence 37 and 14%. Death due to neurologic disease was 44% and 14%. There are several retrospective studies involving relatively small numbers of patients in which surgery followed by WBRT has been compared to surgery alone (4, 21, 22). Smalley and colleagues demonstrated a statistically significant benefit in survival and fewer recurrences in 85 patients who received WBRT following surgery (23). In a second retrospective analysis by the same investigators, the MST among 229 patients was 15 months for those who underwent surgery followed by adjuvant WBRT as compared to 8 months for patients who underwent surgery but did not receive WBRT (24). On the other hand, Hagan et al. found no advantage to WBRT following surgery in patients with melanoma, a radioresistant tumor (22). Likewise, Dosoretz et a/. found no survival advantage to low dose WBRT among 33 patients with resected solitary lesions and no active systemic cancer (21). Review ofthe Stereotactic Radiosurgery Literature There is extensive literature suggesting stereotactic radiosurgery is as good or better than surgical resection in terms of local control and is noninvasive and more cost-effective (25, 26). Over a decade of reports have suggested a role for stereotactic radiosurgery (SRS) in the treatment of metastatic brain tumor (27-39). The development of linear accelerators modified to deliver focused irradiation has expanded the availability of SRS (40-42). Advantages of SRS are ease of administration from the patient's viewpoint (a one-day noninvasive treatment usually performed as an outpatient), the ability to treat metastases located in areas of the brain not amenable to complete surgical resection, the ability to treat multiple metastases in a single session (unlike craniotomy), the ability to treat microscopic projections beyond the visible tumor (in contrast to many surgical tools that may leave clonogens completely untreated at the margin of resection) and the potential to decrease neurosurgery and radiation related morbidity and mortality (21, 43-45). SRS allows delivery of a high dose of focal irradiation in a single fraction to the tumor from multiple angles (46). Brain metastases are ideal targets for SRS because the majority are small «3 em in diameter), most are spherical with distinct tumor margins on contrast enhanced imaging studies and most displace rather than infiltrate normal brain (40). SRS minimizes the amount of radiation received by the non-target regions of the brain, and the area targeted generally does not include functional brain (32, 42). Technology in Cancer Research & Treatment, Volume 2, Number 2, April2003
3 Radiosurgery for Brain Metastases 107 Retrospective analyses show that brain metastases from a large number of different types of malignancies including less radioresponsive malignancies such as colon cancer, renal cell carcinoma and melanoma respond to SRS (32, 35, 38, 46). Local control to complete radiographic obliteration has been achieved in 80 to 90% of cases (36, 39). Noordijk et al. treated 52 brain metastases in 33 patients with SRS (14). At 5.5 months follow up, 10 (29%) patients' metastatic lesions had completely disappeared, 15 (50%) had decreased in size and four had stable intracranial disease. Mehta et al. reported the results of a prospective trial in which patients with single brain metastasis were randomized to undergo surgical resection of the metastasis followed by SRS to the preoperative tumor margins and/or residual tumor or SRS alone (49). MST for patients who received surgery and SRS was 40 weeks compared to 15 weeks for patients who received SRS alone. There were fewer recurrences at the site of the original brain metastasis in patients who underwent surgery plus SRS compared to SRS alone, 20 vs 52%, respectively. The quality of life of patients in the former group was also markedly improved. Variables affecting response and complications include performance status, patient age and lesion size (30, 35, 44, 52). Review ofthe RTOG Radiosurgery Experience The RTOG has been at the forefront of clinical trials on the management of patients with brain metastases since the 1970s. In addition to the trials in the pre-radiosurgery era described in section 1.2, there is now a significant database in the radiosurgery era. The RTOG dose-escalation study (RTOG 9005) reported the maximum tolerated radiosurgery dose in patients with recurrent irradiated primary brain tumors and brain metastases (n=156) for lesions of <!=2.0cm, cm and cm in maximum diameter were 24Gy, 18Gy and 15Gy, respectively (51). Sanghavi et al, recently reported a retrospective multi-institutional recursive partitioning analysis (RPA) suggesting there was a significant survival benefit for patients treated with WBRT plus SRS when compared to an RTOG database of patients treated with WBRT alone and that this benefit existed in all three RPA classes (52). The RTOG RPA classes are defined as follows: Class I: patients with KPS ~ 70, age <65 with a controlled primary tumor and no extracranial metastases; Class III: KPS < 70; and Class II: all others (53). The RTOG has recently completed a prospective randomized trial (RTOG 9508) of WBRT versus WBRT plus SRS for patients with 1-3 brain metastases. WBRT plus SRS provided a survival advantage compared to WBRT alone in each of the following patient categories: i) solitary brain metastases (for which the study was stratified) and the following sub- sets; ii) 1-3 metastases and RPA class I; iii) 1-3 metastases and age < 50 years and; iv) 1-3 metastases and non-small cell lung cancer or any squamous carcinomas. Furthermore, all subsets of patients in the WBRT + SRS group were more likely to have a stable or improved performance status, improved local control and reduced steroid dependence compared to the WBRT alone group. Systemic disease remained the primary cause of death (> 2/3) in both groups. Toxicities and the rate of re-operation were comparable in the two groups. Re-operation pathology showed necrosis in all patients in the WBRT + SRS arm and viable tumor in all patients in the WBRT alone arm (44). Reviewofthe Debate about Whole Brain Radiation Therapy: Pro and Con Despite the wealth of literature referenced above, there remain conflicting data and opposing practice patterns are emerging regarding whether WBRT is beneficial or not when added to SRS. Several prominent institutions are treating selected patients with SRS alone. Pro: As previously discussed, in the Patchell trial in which patients with a single brain metastasis were randomized to surgery alone vs. surgery followed by WBRT. the patients in the WBRT group were less likely to die of neurologic causes than patients in the observation group (14% vs. 44%, P = 0.003). This is despite the fact that among the 70% of patients in the observation group who experienced a brain tumor recurrence, 88% received salvage WBRT either alone or in combination with surgery or SRS. A more recent report from the University of Kentucky shows that despite the use of high resolution treatment planning and every 3 month follow-up MRI in patients with newly diagnosed brain metastases, usc of SRS alone is associated with an increasing risk of brain recurrence with increasing survival time. In addition, the majority of such recurrences are symptomatic and associated with a neurologic deficit (54). Debate is burgeoning regarding whether the quality of life and neurocognitive function of these patients is optimized by the use of WBRT to better control the brain metastases or by avoiding the side effects of WBRT. The Kentucky data clearly would favor the use ofwbrt. Con: A recent report from UCSF by Sneed and associates (55) suggested that radiosurgery alone results in equivalent survival and intracranial control when compared to radiosurgery and WBRT for one to four metastases to brain. In this retrospective report 62 patients treated with radiosurgery alone were compared to 43 treated with both modalities. Survival was 11.3 and 11.1 months, respectively. Remote failure was higher in the radiosurgery group (72 vs. 31%), but high successful salvage resulted in intracranial control 62 and 73% (not significantly different), respectively. It should be noted that selection bias was acknowledged and evident Technoloav in Cancer Research & Treatment, Volume 2, Number2, April 2003
4 108 Sperduto as there was a statistically significant greater number of patients with solitary metastases in the SRS alone arm. The UCSF data, in fact, support the opposite conclusion, that WBRT + SRS is better because it brings a worse prognostic group (multiple metastases) up to the outcomes associated with the good prognostic group (solitary metastases). In other words, if SRS alone cannot achieve outcomes for good prognostic patients better than WBRT + SRS does for poor prognostic patients, then SRS alone is not better, but worse treatment. Furthermore, the WBRT + SRS is more costeffective because patients treated with SRS alone in the UCSF series received salvage SRS more than twice as commonlyas those treated with WBRT + SRS (40% vs 19%) and some patients received SRS more than twice. Clearly WBRT + SRS is more cost-effective than SRS twice. Summary Ongoing prospective randomized trials by the RTOG and ACOSOG will further elucidate the optimal management for patients with brain metastases. Until those data are available, clinicians are encouraged to apply the existing data reviewedhere in conjunction with best clinical judgment. In brief, patients with a solitary metastasis in an operable location and symptomatic mass effect should undergo surgery. Patients with poor performance status (KPS < 70) or more than three brain metastases should receive WBRT alone. For patients with 1-3 brain metastases and KPS ~ 70, should receive WBRT + SRS. Ifthe patient refuses WBRT or needs salvage after WBRT, then SRS alone is appropriate. Clinicians should not be too dogmatic and should always apply the best clinical judgment. References I. Cairncross, J. G. Posner. J. B. Neurological Complications of Systemic Cancer in Oncologic Emergencies. eds., Yarboro. J. W. Bomstein. R. S. Grune and Stratton. New York (1981). 2. Clouston, P. D. DeAngelis. L. M., Posner. J. B. The Spectrum of Neurological Disease in Patients with Systemic Cancer.Ann. Neurol. 3I (1992). 3. Posner. J. B. Chernik, N. L. Intracranial Metastases from Systemic Cancer. In: Advances in Neurology.ed. Bruce S. Schoenberg. Raven Press. New York. pp (1978). 4. Posner. J. B. Management of Brain Metastases. Rev. Neurol (1992). 5. Delattre, J. Y., Krol, G., Thaler. H. T. Posner. J. P. Distribution of Brain Metastases. Arch. Neurol (1988). 6. Cairncross, J. G. Kim. J. H. Posner. J. R. Radiation Therapy for Brain Metastases. Ann. Neurol (1980). 7. Borgelt, B. Gelber. R. Kramer. S., et al. The Palliation of Brain Metastases: Final Results of the First Two Studiesof by the Radiation Therapy Oncology Group. Int. J. Rad. Oncol. BioI. Phys. 6. I (1980). 8. Hoskins. P. J., Crow. J. Ford. H. T. The Influence of Extent and Local Management-on the Outcome of Radiotherapy for Brain Metastases. Int. J. Rad. Oneol. BioI. Phys (1990). 9. Bindal, A. K.. Bindal, R. K.. Hess. K. R. Shiu, A.. Hassenbusch, S. J. Shi, W. M. Sawaya. R. Surgery Versus Radiosurgery in the Treatment of Brain Metastasis. J. Neurosurg (1996). 10. DeAngelis, L. M.. Mandell. L. R. Thaler. T.. Kimmel. D. w.. Galicich, Fuks, Z.. Posner. J. P. The Role of Postoperative Radiotherapy After Resection of Single Brain Metastases. Neurosurgery (1989). II. Auchter. R. M. Lamond. J. P. Alexander.E. Buattti, J. M. Chappell. R. Friedman. W.A. Kinsella.T. J. Levin. A.. Noyes. W. R.. Schultz. e. J.. Loeffler. J. S.. Mehta. M. P. A Multiinstitutional Outcome and Prognostic Factor Analysis of Radiosurgery for Resectable Single Brain Metastasis.lnt1 Radiat Oncol Bioi Phys (1996). 12. Bindal,R. K.. Bindal,A. K.. Sawaya. R. Outcomeof SurgicalTherapy for Metastatic Cancer to the Brain. Adl~ Surg (1997). 13. Ferrara. M., Bizzozero, L.. Talamonti, G., D'Angelo. V.A. Surgical Treatment of 100 Single Brain Metastases: Analysis of the Results. J NeurosurgSci (1990). 14. Noordijk, E. M.. Vecht, C. J. Haaxrne-Reicbe, H.. et al. The Choice of Treatment of Single Brain Metastasis Should be Based on ExtracranialTumor Activity and Age. Int 1 Rad Oncol Bioi Pliys (1994). 15. Patchell. R. A. Posner. J. B. Neurologic Complications of Systemic Cancer. Neurologic Clinics (1985). 16. Sawaya. R. Ligon, B. L.. Bindal, A. K.. Bindal, R. K.. Hess. K. R. Surgical Treatment of Metastatic Brain Tumors. 1 Neurooncol 27, (1996). 17. Patchell, R. A. Tibbs, P. A. Walsh, J. W. Dempsey. R. J.. Maruyama. Y. Kryscio, R. J.. Markesbury,W. R. MacDonald. J. S.. Young.B. A RandomizedTrial of Surgery in the Treatment of Single Brain Metastases to the Brain. N. Eng. J. Med (1993). 18. Vecht, C. J. Haaxma-Reiche, H. Noordjik, E. M. Treatment of Single Brain Metastasis: Radiotherapy Alone or Combined with Neurosurgery?Ann. Neurol. 33, (1993). 19. Patchell. R. A.. Ciprincione, C. Thaler. H. T. et al. Single Brain Metastasis: Surgery Plus Radiation or Radiation Alone. Neurology (1986). 20. Patchell.R. A. TIbbs.P.A. Regine,W.E, Dempsey. R. J.. Mohiuddin, M. Kryscio, R. J. Markesbery. W. R., Foon, K. A. Young, B. Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain:A Randomized Trial. lama (1998). 21. Dosoretz, D. E. Blizer, P. H. Russell. Wang. C. e. Management of Solitary Metastasis to the Brain: The Role of Elective Brain Irradiation Following Complete Surgical Resection. lilt 1 Rad Oncol BioI Phys (1980). 22. Hagan. N. Cirrincione, C. DeAngelis, L. M. The Role of Radiotherapy After Resection of Single Brain Metastases from Melanoma. Neurology (Supplement I) (1989). 23. Smalley. S. R. Laws. E. R.. O'Fallon, J. R. et al. Resection for Solitary BrainMetastasis: Role of Adjuvant Radiationand Prognostic Variables in 229 Patients. J Neurosurg (1992). 24. Smalley. S. R. Schray, M. E, Laws. E. R., O'Fallon, J. R. Adjuvant Radiation Therapy After Surgical Resection of Single Brain Metastasis: Association with Patterns of Failure and Survival. lnt 1 Rad Oncol BioI Phys (1991). 25. Sperduto. P. W. Hall. W. A. The Cost-effectiveness for Alternative Treatments for Single Brain Metastases. In: Radiosurgery. ed. Kondziolka, D. Basel. Karger. I (1996). 26. Rutigliano, M. J. Lundsford, L. D., Kondziolka, D. Strauss. M. J. Khanna. V., Green. M. The Cost Effectiveness of Stereotactic Radiosurgery VersusSurgical Resection in the Treatment of Solitary Metastic Brain Tumors. Neurosurgery (1995). 27. Adler. J. R., Cox. R. S. Kaplan, I.. Martin, D. P. Stereotactic Radiosurgical Treatment of Brain Metastases. J Neurosurg 76, (1992). Technology in CancerResearch & Treatment, Volume 2, Number2, April2003
5 Radiosurgery for Brain Metastases Alexander. E. Siddon, R. L.. Loeffler. 1. S. The Acute Onset of Nausea and Vomiting Following Stereotactic Radiosurgery: Correlation with Total Dose to Area Postrema. Surg. Neurol (1989). 29. Chidel, M. A., Suh. J. H., Greskovich, 1. E. Kupelian, P. A.. Barnett. G. H. Treatment Outcome for Patients with Primary Nonsmall-cell Lung Cancer and Synchronous Brain Metastasis. Radial Oncol lnvcstig 7, (1999). 30. Engenhart, R., Kimmig, B. N.. Hover, K. H.. Wora, 8.. Romahn, J., Lorenz, W., van Kaick, G., Wannenmacher, M. Long-term Followup for Brain Metastases Treated by Percutaneous Sterotactic Single High-dose Irradiation. Cancer 71, (1993). 31. Fuller, B. G., Kaplan, I. D. Adler. J., Cox, R. S.. Bagshaw. M. A. Stereotactic Radiosurgery for Brain Metastases: The Importance of Adjuvant Whole Brain Irradiation. Int J Rad Oneol BioI Phys (1992). 32. Kim. Y. S.. Kondziolka, D., Flickinger. J. C., Lunsford, L. D. Stereotactic Radiosurgery for Patients with Nonsmall Cell Lung Carcinoma Metastatic to the Brain. Cancer 80, (1997). 33. Kjellberg. R. N., Abe, M. Stereotactic Bragg Peak Proton Beam Therapy. In: Modern Stereotactic Neurosurgery. ed., Lundsford, L. D. Martinus Niihoff Publishers, Boston. MA. pp (1988). 34. Lavine. S. Do, Petrovich. Z., Cohen-Gadol, A. A. Masri. L. S. Morton, D. L.. O'Day, S. J. Essner. R., Zelman. V.. Yu, C., Luxton, G., Apuzzo. M. L. Gamma Knife Radiosurgery for Metastatic Melanoma: An Analysis of Survival, Outcome and Complications. Neurosurgery 44, (1999). 35. Loeffler, J. S., Alexander. E., III. Radiosurgery for the Treatment of Intracranial Metasases. In: Stereotactic Radiosurgery. eds.. E. Alexander, III. J. S. Loeffler. L. D. Lunsford. New York, McGraw Hill, (1993). 36. Loeffler, J. S., Kooy, H. Mo, Fine. H. A. Cheng, C. w.. Mannarino, E. G., Tsai, J. S. Alexander. E. III. The Treatment of Recurrent Brain Metastases with Stereotactic Radiosurgery. J. Clin. Oncol (1990). 37. Mehta. M., Noyes, W., Graig, B., Lamond, 1., Auchter, R., French, M., Johnson, M., Levin, A., Badie, B., Robbins, I., Kinsella, T. A Cost-effectiveness and Cost-utility Analysis of Radiosurgery vs. Resection for Single-brain Matastases. lnt, J. Radial. Oncol. BioI. Phys. 39, (\ 997). 38. Mehta, M. P. Radiosurgery for Brain Metastases In: Stereotactic Surgery and Radiosurgery. eds., Desallese, A. A. E. Goetsch. S. J. Medical Physics Publishing. Madison WI (1993). 39. Alexander, E. III, Loeffler, J. S. Radiosurgery using a Modified Linear Accelerator. Stereotactic Radiosurgery (1992). 40. Loeffler, 1. S., Siddon, R. L., Wen, P. Y., Nedzi, L. A.. Alexander, E. III. Stereotactic Radiosurgery of the Brain Using Standard Linear Accelerator: A Study of Early and Late Effects. Radiotherapy Oncol 17, (1990). 41. Philips. M. H., Stelzer, K. J. Griffin, T. W., Mayberg, M. R., Winn. R. Stereotactic Radiosurgery: A Review and Comparison of Methods. J Clin Oncol (1994). 42. DeAngclis, L. Mo, Delattre, J. Y., Posner. J. B. Radiation Induced Dementia in Patients Cured of Brain Metastases. Neurology 39, (1989). 43. Marks, L. B.. Spencer. D. P. The Influence of Volume on the Tolerance of the Brain to Radiosurgery. J Neurosurg (1991). 44. Sperduto. P. Wo, Scott, c.. Andrews, D.. Schell. M.. Werner-Wasik, M., Demas, W.. Ryu, J. K., Gaspar. L.. Curran. W. A Phase III Trial Comparing Whole Brain Irradiation Alone Versus Whole Brain Irradiation Plus Stereotactic Radiosurgery for Patients with One or Three Brain Metastases. Proceedings of the American Society of the American Society for Therapeutic Radiology and Oncology. Plenary Abstract # 5. lnt J Radiat Oncol Phys 51, 2S:3. Presented New Orleans, LA (2002). 45. Lekscll, L. Stereotactic Radiosurgery. J. Neurol. Neurosurg, Psychiatry (\983). 46. Li, Bo,Yu, J., Suntharalingam, M.. Kennedy. A. S., Arnin, P. P.. Chen. Z., Yin, R. Guo, S., Han, T.. Wang, T.. Yu, N.. Song. G.. Wang. L. Comparison ofthree Treatment Options for Single Brain Metastasis from Lung Cancer. IIlI J Cancer (2000). 47. Mori, Y., Kondziolka, D., Flickinger. J. Co, Kirkwood, J. M.. Agarwala, S., Lunsford. L. D. Stereotactic Radiosurgery for Cerebral Metastatic Melanoma: Factors Affecting Local Disease Control and Survival.lnt J Radiat Oncol Bioi Phys (1998). 48. Mori, Y.. Kondziolka, D.. Flickinger. J. c.. Logan. T.. Lunsford, L. D. Stereotactic Radiosurgery for Brain Metasstasis from Renal Cell Carcinoma. Cancer 83, (\998). 49. Mehta. M. P., Rozental, 1. M., Levin. A. B., et al. Defining the Role of Radiosurgery in the Management of Brain Metastases. Int J Rud Oneol Bioi Phys (\992). 50. Fernandez-Viciosos, E., Suh, J. H. Kupelian, P. A.. Sohn, 1. W., Barnett. G. H. Analysis of Prognostic Factors for Patients with Single Brain Metastasis Treated with Stereotactic Radiosurgery. Radiat Oncol lnvestig 5, (1997). 51. Shaw, E., Scott. C., Souhami, L.. Dinapoli, R.. Kline. R., Loeffler, J., Farnan. B. S. Single Dose Radiosurgical Treatment of Recurrent Previously Irradiated Primary Brain Tumors and Brain Metastases: Final Report of RTOG Protocol lnt J Radiation Oncology Bioi Phys (2000). 52. Sanghavi, S. N.. Miranpuri. S. S., Chappell. R., Buati, J. M.. Sneed. P. K.. Suh, J. n., Regine, W. E, Weltman, Eo, King, V. r., Goetsch. S. J., Breneman. J. C.. Sperduto. P. Wo, Scott. Co, Mabanta, So, Mehta, M. Radiosurgery for Patients with Brain Metastases: A Multi-institutional Analysis, Stratified by the RTOG Recursive Partitioning Analysis Methodology. Int. J. Rad. Oncol. BioI. Phys. 51, (2001). 53. Gaspar, L., Scott. C.. Rotman, et al. Recursive Partitioning Analysis (RPA) of Prognostic Factors in Three Radiation Therapy Oncology Group (RTOG) Brain Metastases Trials. Int. J. Rad. Oncol. Bioi. Phys. 37, (1997). 54. Regine, W. E, Huhn, Patchell, et al. Risk of Symptomatic Brain Tumor Recurrence and Neurologic Deficit After Radiosurgery Alone in Patients with Newly Diagnosed Brain Metastases: Results and Implications. Int. J. Rad. Oneol. Bioi. Phys (2002). 55. Sneed, P. K., Lamborn. K. R, Forstner. 1. M.. Mcfsermort. M. W.. Chang, So,Park, E., Gutin, P. H.. Phillips. T. L.. Wara, W. M.. Larson. D. A. Radiosurgery for Brain Metastases: Is Whole Brain Radiotherapy Necessary? lnt. J. Rod. Oncol. Bioi. Phys (1999). Date Received: February 10, 2003 Technology in Cancer Research & Treatment. Volume 2, Number 2, April 2003
Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin
J Neurosurg 104:907 912, 2006 Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin MICHAEL A. VOGELBAUM, M.D., PH.D., LILYANA ANGELOV, M.D., SHIH-YUAN
More informationLaboratory data from the 1970s first showed that malignant melanoma
2265 Survival by Radiation Therapy Oncology Group Recursive Partitioning Analysis Class and Treatment Modality in Patients with Brain Metastases from Malignant Melanoma A Retrospective Study Jeffrey C.
More informationBr a i n metastases occur in 20 40% of all patients. The results of resection after stereotactic radiosurgery for brain metastases.
J Neurosurg 111:825 831, 2009 The results of resection after stereotactic radiosurgery for brain metastases Clinical article Hi d e y u k i Ka n o, M.D., Ph.D., 1,3 Do u g l a s Ko n d z i o l k a, M.D.,
More informationNonsmall Cell Lung Cancer Presenting with Synchronous Solitary Brain Metastasis
1998 Nonsmall Cell Lung Cancer Presenting with Synchronous Solitary Brain Metastasis Chaosu Hu, M.D. 1 Eric L. Chang, M.D. 2 Samuel J. Hassenbusch III, M.D., Ph.D. 3 Pamela K. Allen, Ph.D. 2 Shiao Y. Woo,
More informationSurvival and Intracranial Control of Patients With 5 or More Brain Metastases Treated With Gamma Knife Stereotactic Radiosurgery
ORIGINAL ARTICLE Survival and Intracranial Control of Patients With 5 or More Brain Metastases Treated With Gamma Knife Stereotactic Radiosurgery Ann C. Raldow, BS,* Veronica L. Chiang, MD,w Jonathan P.
More information!"#$%&'()*+,-./01 !"#$ N! !"#$%&'()*+,- !"#$%&'()*+,-)*./01!"#$% &'()*+,-./#0!"#$#%
!"#$%&!"#$ N!!"#$%&'()!" N!!"#$%&'()*+,-./0123456789:;4567 OMN!"#$%!&!"#$%&'!( )*+,-./01!2345678019:;?@!ABC%6 2!"#$%&'()*!+,,-./*012345-678*4509:;?@ABC./$! -.!/0123456*+!789:6;?@A2B!#$6CD
More informationSurgical treatment of multiple brain metastases
J Neurosurg 79:210-216, 1993 Surgical treatment of multiple brain metastases RAJESH K. BINDAL, B.A., RAYMOND SAWAYA, M.D., MILAM E. LEAVENS, M.D., ANO J. JACK LEE, PH.D. Departments of Neurosurgery and
More informationTr a d i t i o n a l ly, WBRT has been the standard approach
Neurosurg Focus 27 (6):E7, 2009 Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy Br i a n J. Ka r l
More informationStereotactic Radiosurgery for Brain Metastasis: Changing Treatment Paradigms. Overall Clinical Significance 8/3/13
Stereotactic Radiosurgery for Brain Metastasis: Changing Treatment Paradigms Jason Sheehan, MD, PhD Departments of Neurosurgery and Radiation Oncology University of Virginia, Charlottesville, VA USA Overall
More informationNeurological Change after Gamma Knife Radiosurgery for Brain Metastases Involving the Motor Cortex
ORIGINAL ARTICLE Brain Tumor Res Treat 2016;4(2):111-115 / pissn 2288-2405 / eissn 2288-2413 http://dx.doi.org/10.14791/btrt.2016.4.2.111 Neurological Change after Gamma Knife Radiosurgery for Brain Metastases
More informationManagement of single brain metastasis: a practice guideline
PRACTICE GUIDELINE SERIES Management of single brain metastasis: a practice guideline A. Mintz MD,* J. Perry MD, K. Spithoff BHSc, A. Chambers MA, and N. Laperriere MD on behalf of the Neuro-oncology Disease
More informationThe Role of Radiation Therapy in the Treatment of Brain Metastases. Matthew Cavey, M.D.
The Role of Radiation Therapy in the Treatment of Brain Metastases Matthew Cavey, M.D. Objectives Provide information about the prospective trials that are driving the treatment of patients with brain
More informationEvidence Based Medicine for Gamma Knife Radiosurgery. Metastatic Disease GAMMA KNIFE SURGERY
GAMMA KNIFE SURGERY Metastatic Disease Evidence Based Medicine for Gamma Knife Radiosurgery Photos courtesy of Jean Régis, Timone University Hospital, Marseille, France Brain Metastases The first report
More informationRESEARCH HUMAN CLINICAL STUDIES
TOPIC RESEARCH HUMAN CLINICAL STUDIES RESEARCH HUMAN CLINICAL STUDIES Radiosurgery to the Surgical Cavity as Adjuvant Therapy for Resected Brain Metastasis Jared R. Robbins, MD* Samuel Ryu, MD* Steven
More informationRadiotherapy for Brain Metastases
Radiotherapy for Brain Metastases Robert B. Den, MD a, David W. Andrews, MD b, * KEYWORDS Brain metastases Treatment approaches SRS WBRT The optimal treatment of brain metastases remains controversial.
More informationPre-operative stereotactic radiosurgery treatment is preferred to post-operative treatment for smaller solitary brain metastases
Aliabadi et al. Chinese Neurosurgical Journal (2017) 3:29 DOI 10.1186/s41016-017-0092-5 CHINESE NEUROSURGICAL SOCIETY RESEARCH CHINESE MEDICAL ASSOCIATION Pre-operative stereotactic radiosurgery treatment
More informationSurgical Management of Brain Metastases
Surgical Management of Brain Metastases Christopher P. Kellner, MD a, Anthony L. D Ambrosio, MD a,b,c, * KEYWORDS Brain Management Metastasis Metastases Resection Surgery Secondary metastases to the brain
More informationBrain metastases arise in 10% 40% of patients
J Neurosurg (Suppl) 117:38 44, 2012 Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone Clinical article
More informationBr a i n metastases are the tumors most frequently. Safety and efficacy of Gamma Knife surgery for brain metastases in eloquent locations
J Neurosurg 113:79 83, 2010 Safety and efficacy of Gamma Knife surgery for brain metastases in eloquent locations Clinical article Ni c o l a s De a, M.D., Mar t i n Bo r d u a s, Br e n d a n Ke n n y,
More informationStereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases
ONCOLOGY REPORTS 29: 407-412, 2013 Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases SHELLY LWU 1, PABLO GOETZ 1, ERIC MONSALVES 1, MANDANA ARYAEE 1, JULIUS
More informationCollection of Recorded Radiotherapy Seminars
IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org The Role of Radiosurgery in the Treatment of Gliomas Luis Souhami, MD Professor Department of Radiation
More informationJAMA. 2006;295:
ORIGINAL CONTRIBUTION Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases A Randomized Controlled Trial Hidefumi Aoyama, MD,
More informationPrognostic Factors for Survival in Patients Treated With Stereotactic Radiosurgery for Recurrent Brain Metastases After Prior Whole Brain Radiotherapy
International Journal of Radiation Oncology biology physics www.redjournal.org Clinical Investigation: Metastases Prognostic Factors for Survival in Patients Treated With Stereotactic Radiosurgery for
More informationBrain metastases are common brain malignant neoplasms
J Neurosurg (Suppl) 117:49 56, 2012 Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non small cell lung cancer
More informationWe have previously reported good clinical results
J Neurosurg 113:48 52, 2010 Gamma Knife surgery as sole treatment for multiple brain metastases: 2-center retrospective review of 1508 cases meeting the inclusion criteria of the JLGK0901 multi-institutional
More informationARROCase Brain Metastases
ARROCase Brain Metastases Colin Hill*, Daniel M. Trifiletti*, Timothy N. Showalter*, Jason P. Sheehan Radiation Oncology* and Neurosurgery University of Virginia Charlottesville, VA Case: HPI 64 year old
More informationOutcome of Surgical Resection of Symptomatic Cerebral Lesions in Non-Small Cell Lung Cancer Patients with Multiple Brain Metastases
ORIGIL ARTICLE Brain Tumor Res Treat 2013;1:64-70 / Print ISSN 2288-2405 / Online ISSN 2288-2413 online ML Comm Outcome of Surgical Resection of Symptomatic Cerebral Lesions in Non-Small Cell Lung Cancer
More informationManagement of Single Brain Metastases Practice Guideline Report #9-1
Management of Single Brain Metastases Practice Guideline Report #9-1 A.P. Mintz, J. Perry, G. Cairncross, A. Chambers and members of the Neuro-oncology Disease Site Group Report Date: August 17, 2004 SUMMARY
More informationFactors influencing survival in patients with breast cancer and single or solitary brain metastasis
Factors influencing survival in patients with breast cancer and single or solitary brain metastasis A. Niwińska, K. Pogoda, M. Murawska, P. Niwiński To cite this version: A. Niwińska, K. Pogoda, M. Murawska,
More informationRadiotherapy and Brain Metastases. Dr. K Van Beek Radiation-Oncologist BSMO annual Meeting Diegem
Radiotherapy and Brain Metastases Dr. K Van Beek Radiation-Oncologist BSMO annual Meeting Diegem 24-02-2017 Possible strategies Watchful waiting Surgery Postop RT to resection cavity or WBRT postop SRS
More informationAUTHOR S PERSONAL COPY
Clinical Outcomes of Stereotactic Radiosurgery in the Treatment of Patients with Metastatic Brain Tumors Ameer L. Elaimy 1,2, Alexander R. Mackay 1,3, Wayne T. Lamoreaux 1,2, Robert K. Fairbanks 1,2, John
More informationSelecting the Optimal Treatment for Brain Metastases
Selecting the Optimal Treatment for Brain Metastases Clinical Practice Today CME Co-provided by Learning Objectives Upon completion, participants should be able to: Understand the benefits, limitations,
More informationCollection of Recorded Radiotherapy Seminars
IAEA Human Health Campus Collection of Recorded Radiotherapy Seminars http://humanhealth.iaea.org The Management of Brain Metastases Dr. Luis Souhami Professor Department of Radiation Oncology University,
More informationOriginal Article Value of Adding Boost to Whole Brain Radiotherapy after Surgical Resection of Limited Brain Metastases
Egyptian Journal of Neurosurgery Volume 29 / No. 4 / October - December 2014 39-44 Original Article Value of Adding Boost to Whole Brain Radiotherapy after Surgical Resection of Limited Brain Metastases
More informationSUCCESSFUL TREATMENT OF METASTATIC BRAIN TUMOR BY CYBERKNIFE: A CASE REPORT
SUCCESSFUL TREATMENT OF METASTATIC BRAIN TUMOR BY CYBERKNIFE: A CASE REPORT Cheng-Ta Hsieh, 1 Cheng-Fu Chang, 1 Ming-Ying Liu, 1 Li-Ping Chang, 2 Dueng-Yuan Hueng, 3 Steven D. Chang, 4 and Da-Tong Ju 1
More informationVINCENT KHOO. 8 th EIKCS Symposium: May 2013
8 th EIKCS Symposium: May 2013 VINCENT KHOO Royal Marsden NHS Foundation Trust & Institute of Cancer Research St George s Hospital & University of London Austin Health & University of Melbourne Disclosures
More informationCME. Special Article. Received 27 October 2011; revised 9 December 2011; accepted 15 December Practical Radiation Oncology (2012) 2,
Practical Radiation Oncology (2012) 2, 210 225 CME www.practicalradonc.org Special Article Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation
More informationRadiosurgery for Brain Metastases
Radiosurgery for Brain Metastases Jay Jagannathan, Brian J. Williams, Jason P. Sheehan Affiliation (all authors): 1Department of Neurosurgery University of Virginia Health Sciences Center University of
More informationA prospective pilot study of two-session Gamma Knife surgery for large metastatic brain tumors
J Neurooncol (2012) 109:159 165 DOI 10.1007/s11060-012-0882-8 CLINICAL STUDY A prospective pilot study of two-session Gamma Knife surgery for large metastatic brain tumors Shoji Yomo Motohiro Hayashi Claire
More informationPalliative radiotherapy in lung cancer
New concepts and insights regarding the role of radiation therapy in metastatic disease Umberto Ricardi University of Turin Department of Oncology Radiation Oncology Palliative radiotherapy in lung cancer
More informationTreatment of Recurrent Brain Metastases
Treatment of Recurrent Brain Metastases Penny K. Sneed, M.D. Dept. of Radiation Oncology University of California San Francisco Background Brain metastases occur in 8.5-15% of cancer pts in population-
More informationEvidence Based Medicine for Gamma Knife Radiosurgery. Metastatic Disease GAMMA KNIFE SURGERY
GAMMA KNIFE SURGERY Metastatic Disease Evidence Based Medicine for Gamma Knife Radiosurgery Photos courtesy of Jean Régis, Timone University Hospital, Marseille, France Brain Metastases The first report
More informationOutcomes in patients with brain metastasis from esophageal carcinoma
Original Article Outcomes in patients with brain metastasis from esophageal carcinoma Nishi Kothari 1, Eric Mellon 2, Sarah E. Hoffe 2, Jessica Frakes 2, Ravi Shridhar 3, Jose Pimiento 1, Ken Meredith
More informationCerebral metastases occur in 20% 40% of cancer
See the corresponding editorial, DOI: 10.3171/2012.1.JNS12103. DOI: 10.3171/2012.4.JNS11870 Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10
More informationMarie-Adele S Kress 1*, Eric Oermann 2, Matthew G Ewend 2, Riane B Hoffman 2, Huma Chaudhry 3 and Brian Collins 1
Kress et al. Radiation Oncology 2013, 8:64 RESEARCH Open Access Stereotactic radiosurgery for single brain metastases from non-small cell lung cancer: progression of extracranial disease correlates with
More informationImaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors
Journal of Neuro-Oncology 56: 175 181, 2002. 2002 Kluwer Academic Publishers. Printed in the Netherlands. Clinical Study Imaging changes after stereotactic radiosurgery of primary and secondary malignant
More informationTania Kaprealian, M.D. Assistant Professor UCLA Department of Radiation Oncology August 22, 2015
Tania Kaprealian, M.D. Assistant Professor UCLA Department of Radiation Oncology August 22, 2015 Most common brain tumor, affecting 8.5-15% of cancer patients. Treatment options: Whole brain radiation
More informationHong Kong Hospital Authority Convention 2018
Hong Kong Hospital Authority Convention 2018 Stereotactic Radiosurgery in Brain Metastases - Development of the New Treatment Paradigm in HA, Patients Profiles and Their Clinical Outcomes 8 May 2018 Dr
More informationResearch Article Have Changes in Systemic Treatment Improved Survival in Patients with Breast Cancer Metastatic to the Brain?
Oncology Volume 2008, Article ID 417137, 5 pages doi:10.1155/2008/417137 Research Article Have Changes in Systemic Treatment Improved Survival in Patients with Breast Cancer Metastatic to the Brain? Carsten
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: Original Effective Date: MM.05.008 05/12/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 04/01/2015
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: Original Effective Date: MM.05.008 05/12/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 03/01/2013 Section:
More informationAlleinige Radiochirurgie und alleinige Systemtherapie zwei «extreme» Entwicklungen in der Behandlung von Hirnmetastasen?
Department of Radiation Oncology Chairman: Prof. Dr. Matthias Guckenberger Alleinige Radiochirurgie und alleinige Systemtherapie zwei «extreme» Entwicklungen in der Behandlung von Hirnmetastasen? Matthias
More informationOptimal Management of Isolated HER2+ve Brain Metastases
Optimal Management of Isolated HER2+ve Brain Metastases Eliot Sims November 2013 Background Her2+ve patients 15% of all breast cancer Even with adjuvant trastuzumab 10-15% relapse Trastuzumab does not
More informationBaskent University, School of Medicine, Adana Practice and Research Center, Department of Neurosurgery, Adana, Turkey 2
DOI: 0.537/09-549.JTN.483-5. Received: 0.04.205 / Accepted: 25.08.205 Published Online: 6.02.206 Original Investigation Prognostic Impact of Histologic Subtype in Non-Small Cell Lung Cancer Patients Treated
More informationOutcomes after Reirradiation for Brain Metastases
Original Article PROGRESS in MEDICAL PHYSICS Vol. 26, No. 3, September, 2015 http://dx.doi.org/10.14316/pmp.2015.26.3.137 Outcomes after Reirradiation for Brain Metastases Jesang Yu, Ji Hoon Choi, Sun
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: Original Effective Date: MM.05.008 05/12/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 11/20/2015
More informationClinical Commissioning Policy: Stereotactic Radiosurgery / Radiotherapy For Cerebral Metastases. December Reference : NHSCB/D5/1
Clinical Commissioning Policy: Stereotactic Radiosurgery / Radiotherapy For Cerebral Metastases December 2012 Reference : NHSCB/D5/1 NHS Commissioning Board Clinical Commissioning Policy: Stereotactic
More informationA Population-Based Study on the Uptake and Utilization of Stereotactic Radiosurgery (SRS) for Brain Metastasis in Nova Scotia
A Population-Based Study on the Uptake and Utilization of Stereotactic Radiosurgery (SRS) for Brain Metastasis in Nova Scotia Gaurav Bahl, Karl Tennessen, Ashraf Mahmoud-Ahmed, Dorianne Rheaume, Ian Fleetwood,
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: Original Effective Date: MM.05.008 05/12/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 04/01/2017
More informationThe incidence of malignant melanoma is among the. Surgical management of melanoma brain metastases in patients treated with immunotherapy
J Neurosurg 115:30 36, 2011 Surgical management of melanoma brain metastases in patients treated with immunotherapy Clinical article Russell R. Lonser, M.D., 1 Debbie K. Song, M.D., 1 Jacob Klapper, M.D.,
More informationMehmet Ufuk ABACIOĞLU Neolife Medical Center, İstanbul, Turkey
Updated Oncology 2015: State of the Art News & Challenging Topics CURRENT STATUS OF STEREOTACTIC RADIOSURGERY IN BRAIN METASTASES Mehmet Ufuk ABACIOĞLU Neolife Medical Center, İstanbul, Turkey Bucharest,
More informationA prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma
British Journal of Cancer (4) 91, 829 833 All rights reserved 7 9/4 $3. www.bjcancer.com A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic
More informationStereotactic Radiosurgery and Stereotactic Body Radiation Therapy
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Policy Number: Original Effective Date: MM.05.008 05/12/1999 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST 04/01/2014 Section:
More informationMetastasi cerebrali La Radioterapia: tecnica, frazionamento, radiosensibilizzanti
Metastasi cerebrali La Radioterapia: tecnica, frazionamento, radiosensibilizzanti Brain Metastases Radiation Therapy of multiple brain metastases Is treatment appropriate? - Survival - QoL Brain Metastases
More informationOriginal Article A Meta-analysis evaluating stereotactic radiotherapy combined with WBRT versus SRT alone for the NSCLC patients with brain metastases
Int J Clin Exp Med 2017;10(1):675-683 www.ijcem.com /ISSN:1940-5901/IJCEM0040682 Original Article A Meta-analysis evaluating stereotactic radiotherapy combined with WBRT versus SRT alone for the NSCLC
More informationPROCARBAZINE, lomustine, and vincristine (PCV) is
RAPID PUBLICATION Procarbazine, Lomustine, and Vincristine () Chemotherapy for Anaplastic Astrocytoma: A Retrospective Review of Radiation Therapy Oncology Group Protocols Comparing Survival With Carmustine
More informationPrescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastases
Leeman et al. Radiation Oncology 2012, 7:107 RESEARCH Open Access Prescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastases Jonathan E Leeman
More informationPRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM BRAIN METASTASES CNS Site Group Brain Metastases Author: Dr. Norm Laperriere Date: February 20, 2018 1. INTRODUCTION
More informationUpdate on management of metastatic brain disease. Peter Hoskin Mount Vernon Cancer Centre Northwood UK
Update on management of metastatic brain disease Peter Hoskin Mount Vernon Cancer Centre Northwood UK Incidence 15-30% of patients with solid tumours will develop brain metastases Most common primary sites
More informationMultiple Brain Metastases EVIDENCE TABLE
. Posner JB. Management of brain metastases. Rev Neurol (Paris). 992;48(6-7):477-487. 2. Wen PY, Black PM, Loeffler JS. Metastatic brain cancer. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer, principles
More informationStage III non small cell lung cancer and metachronous brain metastases
General Thoracic Surgery Stage III non small cell lung cancer and metachronous brain metastases Nader Moazami, MD a Thomas W. Rice, MD a Lisa A. Rybicki, MS b David J. Adelstein, MD c Sudish C. Murthy,
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,800 116,000 120M Open access books available International authors and editors Downloads Our
More informationCombined surgical resection and stereotactic radiosurgery for treatment of cerebral metastases
Available online at www.sciencedirect.com Radiosurgery Combined surgical resection and stereotactic radiosurgery for treatment of cerebral metastases David D. Limbrick Jr, MD, PhD a,, Eriks A. Lusis, MD
More informationJefferson Digital Commons. Thomas Jefferson University. Mark E Linskey Department of Neurosurgery, University of California-Irvine Medical Center
Thomas Jefferson University Jefferson Digital Commons Department of Neurosurgery Faculty Papers Department of Neurosurgery 1-1-2010 The role of stereotactic radiosurgery in the management of patients with
More informationHypofractionated radiation therapy for glioblastoma
Hypofractionated radiation therapy for glioblastoma Luis Souhami, MD, FASTRO Professor McGill University Department of Oncology, Division of Radiation Oncology Montreal Canada McGill University Health
More informationB bidity in cancer patients. Recent data suggest that
Surgical Treatment of Brain Metastases Clinical and Computerized Tomography Evaluation of the Results of Treatment NARAYAN SUNDARESAN, MD, AND JOSEPH H. GALICICH, MD The results of treatment of brain metastases
More informationORIGINAL ARTICLE. Annals of Oncology 28: , 2017 doi: /annonc/mdx332 Published online 27 June 2017
Annals of Oncology 28: 2588 2594, 217 doi:1.193/annonc/mdx332 Published online 27 June 217 ORIGINAL ARTICLE Whole brain radiotherapy after stereotactic radiosurgery or surgical resection among patients
More informationPotential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases
clinical article J Neurosurg 123:1261 1267, 2015 Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases *Jessica M. Frakes, MD,
More informationMinesh Mehta, Northwestern University. Chicago, IL
* Minesh Mehta, Northwestern University Chicago, IL Consultant: Adnexus, Bayer, Merck, Tomotherapy Stock Options: Colby, Pharmacyclics, Procertus, Stemina, Tomotherapy Board of Directors: Pharmacyclics
More informationCase Report Prolonged Survival following Repetitive Stereotactic Radiosurgery in a Patient with Intracranial Metastatic Renal Cell Carcinoma
Case Reports in Neurological Medicine Volume 2015, Article ID 872915, 5 pages http://dx.doi.org/10.1155/2015/872915 Case Report Prolonged Survival following Repetitive Stereotactic Radiosurgery in a Patient
More informationGamma Knife Radiosurgery A tool for treating intracranial conditions. CNSA Annual Congress 2016 Radiation Oncology Pre-congress Workshop
Gamma Knife Radiosurgery A tool for treating intracranial conditions CNSA Annual Congress 2016 Radiation Oncology Pre-congress Workshop ANGELA McBEAN Gamma Knife CNC State-wide Care Coordinator Gamma Knife
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our
More informationLiang-Hua Ma, Guang Li *, Hong-Wei Zhang, Zhi-Yu Wang, Jun Dang, Shuo Zhang and Lei Yao
Ma et al. Radiation Oncology (2016) 11:92 DOI 10.1186/s13014-016-0667-x RESEARCH Open Access The effect of non-small cell lung cancer histology on survival as measured by the graded prognostic assessment
More informationSurgical treatment of primary lung cancer with synchronous brain metastases
General Thoracic Surgery CHD GTS ACD GTS CSP TX Surgical treatment of primary lung cancer with synchronous brain metastases Peter S. Billing, MD Daniel L. Miller, MD Mark S. Allen, MD Claude Deschamps,
More informationANALYSIS OF TREATMENT OUTCOMES WITH LINAC BASED STEREOTACTIC RADIOSURGERY IN INTRACRANIAL ARTERIOVENOUS MALFORMATIONS
ANALYSIS OF TREATMENT OUTCOMES WITH LINAC BASED STEREOTACTIC RADIOSURGERY IN INTRACRANIAL ARTERIOVENOUS MALFORMATIONS Dr. Maitri P Gandhi 1, Dr. Chandni P Shah 2 1 Junior resident, Gujarat Cancer & Research
More informationComparative Analysis of Efficacy and Safety of Multisession Radiosurgery to Single Dose Radiosurgery for Metastatic Brain Tumors
ORIGINAL ARTICLE Brain Tumor Res Treat 2015;3(2):95-102 / pissn 2288-2405 / eissn 2288-2413 http://dx.doi.org/10.14791/btrt.2015.3.2.95 Comparative Analysis of Efficacy and Safety of Multisession Radiosurgery
More informationBrain metastases: changing visions
Brain metastases: changing visions Roberto Spiegelmann, MD Baiona, 2014 Head, Stereotactic Radiosurgery Unit Dept of Neurosurgery, Chaim Sheba Medical Center Tel Hashomer, Israel The best current estimate
More informationGamma Knife Surgery for Brain Metastasis from Renal Cell Carcinoma : Relationship Between Radiological Characteristics and Initial Tumor Response
online ML Comm www.jkns.or.kr Clinical Article Jin Wook Kim, M.D. Jung Ho Han, M.D. Chul-Kee Park, M.D. Hyun-Tai Chung, Ph.D. Sun Ha Paek, M.D. Dong Gyu Kim, M.D. Department of Neurosurgery Seoul National
More informationSee the corresponding editorial in this issue, pp J Neurosurg 114: , 2011
See the corresponding editorial in this issue, pp 790 791. J Neurosurg 114:792 800, 2011 Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer Clinical article
More informationPlace of tumor bed radiosurgery and focal radiotherapy following resec7on of brain metastases: A new paradigm Lucyna Kepka
Place of tumor bed radiosurgery and focal radiotherapy following resec7on of brain metastases: A new paradigm Lucyna Kepka Department of Radia7on Oncology; M. Sklodowska- Curie Memorial Cancer Center and
More informationProspective Assessment of Patient-Rated Symptoms Following Whole Brain Radiotherapy for Brain Metastases
18 Journal of Pain and Symptom Management Vol. 30 No. 1 July 2005 Original Article Prospective Assessment of Patient-Rated Symptoms Following Whole Brain Radiotherapy for Brain Metastases Edward Chow,
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,100 116,000 120M Open access books available International authors and editors Downloads Our
More informationCharacteristics of long-term survivors of brain metastases from lung cancer
reports of practical oncology and radiotherapy 1 6 (2 0 1 1) 49 53 available at www.sciencedirect.com journal homepage: http://www.rpor.eu/ Original article Characteristics of long-term survivors of brain
More informationReview Article Surgical Brain Metastases: Management and Outcome Related to Prognostic Indexes: A Critical Review of a Ten-Year Series
International Scholarly Research Network ISRN Surgery Volume 2011, Article ID 207103, 8 pages doi:10.5402/2011/207103 Review Article Surgical Brain Metastases: Management and Outcome Related to Prognostic
More informationSurgical Outcomes of Hemorrhagic Metastatic Brain Tumors
pissn 1598-2998 eissn 2005-9256 Cancer Res Treat. 2011;43(2):102-107 Original Article DOI 10.4143/crt.2011.43.2.102 Open Access Surgical Outcomes of Hemorrhagic Metastatic Brain Tumors Heon Yoo, MD, PhD
More informationPatients with Single Brain Metastasis from Non-Small Cell Lung Cancer Equally Benefit from Stereotactic Radiosurgery and Surgery: A Systematic Review
e-issn 1643-3750 DOI: 10.12659/MSM.892405 Received: 2014.09.05 Accepted: 2014.09.23 Published: 2015.01.12 Patients with Single Brain Metastasis from Non-Small Cell Lung Cancer Equally Benefit from Stereotactic
More informationKey words: brain neoplasms; lung neoplasms; neoplasm metastasis; neurosurgery; survival rate; thoracic surgery
Surgical Management of Non-small Cell Lung Cancer With Synchronous Brain Metastases* Pierre Bonnette, MD; Philippe Puyo, MD; Christophe Gabriel, MD; Roger Giudicelli, MD; Jean-François Regnard, MD; Marc
More informationStereotactic Radiosurgery of World Health Organization Grade II and III Intracranial Meningiomas
Stereotactic Radiosurgery of World Health Organization Grade II and III Intracranial Meningiomas Treatment Results on the Basis of a 22-Year Experience Bruce E. Pollock, MD 1,2 ; Scott L. Stafford, MD
More informationThe role of WBRT in the management of a resected. Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis
J Neurosurg 114:1585 1591, 2011 Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis Clinical article Courtney A. Jensen, M.D., 1 Michael D. Chan, M.D., 1 Thomas P. McCoy,
More informationDoes gamma knife surgery stimulate cellular immune response to metastatic brain tumors? A histopathological and immunohistochemical study
J Neurosurg (Suppl) 102:180 184, 2005 Does gamma knife surgery stimulate cellular immune response to metastatic brain tumors? A histopathological and immunohistochemical study GYÖRGY T. SZEIFERT, M.D.,
More information